PUBLISHER: Grand View Research | PRODUCT CODE: 1790303
PUBLISHER: Grand View Research | PRODUCT CODE: 1790303
External Catheters Market Summary
The global external catheters market size was estimated at USD 2.82 billion in 2024 and is projected to reach USD 4.95 billion by 2033, growing at a CAGR of 6.49% from 2025 to 2033. This growth is driven by the rising geriatric population and increasing prevalence of urological disorders such as urinary incontinence and prostate-related conditions.
Moreover, the growing adoption of home healthcare and technological advancements in catheter design and materials are further boosting market demand. The increasing prevalence of urological disorders is a key factor driving growth in the external catheters market. In 2025, OU Health reported that nearly 80 million women in the U.S. experience urinary incontinence (UI), affecting 1 in 2 women. Additionally, data from City of Hope in November 2024 revealed that 11% to 34% of older men experience UI, with 2% to 11% reporting daily occurrences. This substantial burden highlights a growing need for non-invasive urinary management solutions, supporting the continued expansion of the external catheters segment in the coming years.
In addition to the rising burden of urinary incontinence, the increasing prevalence of cancers-such as bladder cancer, prostate cancer, and ovarian cancer-is further contributing to the growing demand for external catheters. Patients undergoing treatment for these cancers often experience urinary complications or require temporary catheterization due to surgery. External catheters, also known as condom catheters, offer a less invasive and more comfortable solution for managing urinary output in such cases, particularly for patients with limited mobility or sensitivity post-treatment. As these cancers continue to rise globally, the need for reliable, non-invasive urinary management options like external catheters is expected to increase, driving sustained market growth.
The increasing preference for external catheters or condom catheters, particularly among female patients, is anticipated to create significant growth opportunities in the market. Several companies in the industry have already reported encouraging feedback, reinforcing the market potential.
Furthermore, the availability of reimbursement for external catheters for both male and female patients is expected to support market adoption significantly. Reimbursement policies reduce the financial burden on patients and healthcare providers, encouraging wider usage and accessibility. This support is particularly crucial in long-term care and chronic condition management settings.
In addition, companies are receiving reimbursement approvals for external catheters. For instance, in April 2023, Ur24 Technology, Inc., a privately held medical device company, achieved a significant milestone by securing Medicare reimbursement approval for its TrueClr external catheter system. Such reimbursement approvals are anticipated to support the market expansion in the coming years.
Global External Catheters Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global external catheters market report based on product, material, gender, end use, and region: